NewEdge Advisors’s Pediatrix Medical MD Stock Holding History

NewEdge Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12	Closed	–	–	3859
2022 Q4	$0	Buy	+12	New	+$196	﹤0.01%	4163
2017 Q3	–	Sell	-81	Closed	-$4.68K	–	806
2017 Q2	$4.68K	Buy	+81	New	+$4.8K	﹤0.01%	1162

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NewEdge Advisors's MD Position: Q1 2023 in Review

NewEdge Advisors sold out of Pediatrix Medical (MD) in Q1 2023, closing a stake of 12 shares.

NewEdge Advisors first reported a position in MD in Q2 2017 and held it in 2 quarters. The position peaked at $4.68K in Q2 2017. 214 funds tracked by Wall St. Rank hold MD as of Q1 2023.

NewEdge Advisors reported no remaining Pediatrix Medical position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 12 Pediatrix Medical shares in Q1 2023.
NewEdge Advisors first reported a position in Pediatrix Medical in Q2 2017 and held it in 2 quarters.
NewEdge Advisors's Pediatrix Medical position peaked at $4.68K in Q2 2017.
214 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.